Page last updated: 2024-08-24

liarozole and B-Cell Chronic Lymphocytic Leukemia

liarozole has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aboraia, AS; Brancale, A; DeLuca, HF; Ferla, S; Ochalek, JT; Pepper, CJ; Simons, C; Zhu, J1

Other Studies

1 other study(ies) available for liarozole and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Small-molecule inhibitors of 25-hydroxyvitamin D-24-hydroxylase (CYP24A1): synthesis and biological evaluation.
    Journal of medicinal chemistry, 2014, Sep-25, Volume: 57, Issue:18

    Topics: Antineoplastic Agents; Catalytic Domain; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Cytochrome P-450 Enzyme Inhibitors; Heme; Humans; Imidazoles; Inhibitory Concentration 50; Leukemia, Lymphocytic, Chronic, B-Cell; Models, Molecular; Sequence Homology, Amino Acid; Structure-Activity Relationship; Vitamin D3 24-Hydroxylase

2014